News
The FDA recalled some chocolate products by the Weaver Nut Company chocolate, warning about possible serious to ...
Class II recalls from the FDA indicate a potential risk to consumer safety where use or exposure to the product may cause ...
The board has charged the Iowa-licensed compounding pharmacy FarmaKeio with violating provisions of the federal Food, Drug and Cosmetics Act.
U.S. health officials have expanded warnings about a rare heart side effect associated with the two leading COVID-19 vaccines.
Three years after federal regulators issued a warning about a mail-order pharmaceutical company, the Iowa Board of Pharmacy is taking action.
The warning letters deal with a range of violations involving items from personal hygienic products to mismarketed analgesics.
Houston-based Empower Pharmacy has a decade of violations that raise serious questions about the pharmacy’s adherence to rules designed to ensure quality and safety.
A compounding pharmacy recently roped into Lilly’s fight against knockoff GLP-1s has landed in the FDA’s crosshairs for the second time in a year.
In September 2021, the FDA and the Federal Trade Commission issued warning letters to 10 companies for illegally selling dietary supplements claiming to cure, treat, mitigate, or prevent diabetes.
But the letter writers urged the ministry and the college to intensify investigations, increase oversight of pharmacy operations in the Downtown Eastside, implement stricter accountability ...
Fagron (ARSUF) has refocused its M&A strategy, regaining market trust despite recent FDA issues. Read why I think the stock is a buy.
Some letters are not posted for public view until weeks or months after they are sent. Business owners have 15 days to respond to FDA warning letters.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results